Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Douglas A. Coyle
The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases
Medical Decision Making
Health Policy
Related publications
Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Pcp30 - Comparison Regarding the Transparency of Reimbursement Decisions for Pharmaceuticals Used to Treat Depression in Hungary, Romania, Turkey and Cis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reimbursement Decisions in Oncology Drugs: An International Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Time to Reimbursement for Oncology Drugs in EU5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ten Best Readings Relating to Rare Lymphoproliferative and Histiocytic Diseases
Cancer Control
Medicine
Oncology
Hematology
Psy184 - Hta and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers?s?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Supporting Medical Decisions for Treating Rare Diseases Through Genetic Programming
Lecture Notes in Computer Science
Computer Science
Theoretical Computer Science
The Need for Accountability and Transparency in Intercollegiate Athletic Medicine
Journal of Athletic Training
Sports Medicine
Physical Therapy
Sports Science
Sports Therapy
Orthopedics
Medicine
Rehabilitation
Psy158 - A Pragmatic Literature Review to Identify Economic Outcomes for Repurposed Drugs in Rare Diseases
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
